Quarterly report · Q3
2927.TEDINET S100OQFH
Period2021-09-01 → 2022-05-31
Filed2022-07-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.7bn | 2021-09-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥22.4bn | 2020-09-01 → 2021-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.5bn | 2020-09-01 → 2021-05-31 | Cons. | Net sales |
| Operating income | ¥683m | 2021-09-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2020-09-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥988m | 2021-09-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2020-09-01 → 2021-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2020-09-01 → 2021-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥902m | 2021-09-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2020-09-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥536m | 2021-09-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2020-09-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2020-09-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥535m | 2021-09-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2020-09-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥36.6bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥35.8bn | at 2021-08-31 | Cons. | Assets |
| Total assets | ¥32.9bn | at 2021-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥24.5bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥23.1bn | at 2021-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.2bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2021-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.2bn | at 2021-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.2bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.2bn | at 2021-08-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥38.12 | 2021-09-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.29 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.12 | 2020-09-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.89 | 2020-09-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.11 | 2021-03-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥37.93 | 2021-09-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥106.3 | 2020-09-01 → 2021-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥97.38 | 2020-09-01 → 2021-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 33.2% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.7% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 27
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2021-09-01 → 2022-05-31 | ¥32m |
| Otherother segments | revenue external | 2021-09-01 → 2022-05-31 | ¥32m |
| Otherother segments | segment profit | 2021-09-01 → 2022-05-31 | −¥14m |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥3.5bn |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥3.5bn |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | segment profit | 2021-09-01 → 2022-05-31 | −¥129m |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥634m |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥634m |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | segment profit | 2021-09-01 → 2022-05-31 | −¥299m |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥11.2bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥11.2bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | segment profit | 2021-09-01 → 2022-05-31 | ¥1.4bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥1.3bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥1.3bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | segment profit | 2021-09-01 → 2022-05-31 | ¥128m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-05-31 | ¥16.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-05-31 | ¥16.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-05-31 | ¥1.1bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue | 2020-09-01 → 2021-05-31 | ¥13.3bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue external | 2020-09-01 → 2021-05-31 | ¥13.3bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | segment profit | 2020-09-01 → 2021-05-31 | ¥2.3bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue | 2020-09-01 → 2021-05-31 | ¥1.1bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue external | 2020-09-01 → 2021-05-31 | ¥1.1bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | segment profit | 2020-09-01 → 2021-05-31 | ¥94m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-09-01 → 2021-05-31 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-09-01 → 2021-05-31 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-09-01 → 2021-05-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 370
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)戸 城 秀 樹 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)橋 本 剛 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 14495207000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 16692468000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 22368076000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1907314000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 987760000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2161969000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1359146000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 535879000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1495554000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1402305000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 562814000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1516546000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 12203436000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 12180393000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 12660917000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 32879229000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 36634750000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 35752403000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 97.89 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 38.12 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 107.12 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 97.38 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 37.93 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 106.30 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.347 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.332 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.331 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 45.11 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 16.29 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 14387699 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 14387699 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 14387699 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 14387699 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 362500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 14021200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 140212 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 3999 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 14387699 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 140212 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 362500 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |